메뉴 건너뛰기




Volumn 20, Issue 4, 2014, Pages 385-392

Confirmation of reported aspirin use in community studies: Utility of serum thromboxane B2 measurement

Author keywords

aspirin; cardiovascular prevention; compliance; nonsteroidal anti inflammatory drug; NSAID

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; THROMBOXANE B2;

EID: 84899028752     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029613486537     Document Type: Article
Times cited : (18)

References (67)
  • 1
    • 0037065502 scopus 로고    scopus 로고
    • Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
    • Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002 ; 324 (7329). 71-86
    • (2002) BMJ , vol.324 , Issue.7329 , pp. 71-86
  • 2
    • 0035124920 scopus 로고    scopus 로고
    • Platelet-active drugs: The relationships among dose, effectiveness, and side effects
    • Patrono C, Coller B, Dalen JE, et al. Platelet-active drugs: the relationships among dose, effectiveness, and side effects. Chest. 2001 ; 119 (suppl 1). 39S - 63S
    • (2001) Chest , vol.119 , Issue.SUPPL. 1
    • Patrono, C.1    Coller, B.2    Dalen, J.E.3
  • 3
    • 0037190695 scopus 로고    scopus 로고
    • Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events
    • Weisman SM, Graham DY. Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events. Arch Intern Med. 2002 ; 162 (19). 2197-2202
    • (2002) Arch Intern Med , vol.162 , Issue.19 , pp. 2197-2202
    • Weisman, S.M.1    Graham, D.Y.2
  • 4
    • 63849141400 scopus 로고    scopus 로고
    • Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement
    • Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009 ; 150 (6). 396-404
    • (2009) Ann Intern Med , vol.150 , Issue.6 , pp. 396-404
  • 5
    • 79451474588 scopus 로고    scopus 로고
    • Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: A guideline for healthcare professionals from the american heart association/american stroke association
    • Furie KL, Kasner SE, Adams RJ, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke. 2011 ; 42 (1). 227-276
    • (2011) Stroke , vol.42 , Issue.1 , pp. 227-276
    • Furie, K.L.1    Kasner, S.E.2    Adams, R.J.3
  • 6
    • 79251601596 scopus 로고    scopus 로고
    • Guidelines for the primary prevention of stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association
    • Goldstein LB, Bushnell CD, Adams RJ, et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011 ; 42 (2). 517-584
    • (2011) Stroke , vol.42 , Issue.2 , pp. 517-584
    • Goldstein, L.B.1    Bushnell, C.D.2    Adams, R.J.3
  • 7
    • 84866035006 scopus 로고    scopus 로고
    • 2011
    • Brott TG, Halperin JL, Abbara S, et al. ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/ CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery Developed in Collaboration With the American Academy of Neurology and Society of Cardiovascular Computed Tomography. J Am Coll Cardiol. 2011 2011 ; 57 (8). 1002-1044
    • (2011) J Am Coll Cardiol , vol.57 , Issue.8 , pp. 1002-1044
    • Brott, T.G.1    Halperin, J.L.2    Abbara, S.3
  • 8
    • 84856794168 scopus 로고    scopus 로고
    • Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
    • Vandvik PO, Lincoff AM, Gore JM, et al. Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 ; 141 (suppl 2). e637S - e668S
    • (2012) Chest , vol.141 , Issue.SUPPL. 2
    • Vandvik, P.O.1    Lincoff, A.M.2    Gore, J.M.3
  • 9
    • 84859793751 scopus 로고    scopus 로고
    • Underuse of aspirin for primary and secondary prevention of cardiovascular disease events in women
    • Rivera CM, Song J, Copeland L, Buirge C, Ory M, McNeal CJ. Underuse of aspirin for primary and secondary prevention of cardiovascular disease events in women. J Womens Health (Larchmt). 2012 ; 21 (4). 379-387
    • (2012) J Womens Health (Larchmt) , vol.21 , Issue.4 , pp. 379-387
    • Rivera, C.M.1    Song, J.2    Copeland, L.3    Buirge, C.4    Ory, M.5    McNeal, C.J.6
  • 10
    • 0030027846 scopus 로고    scopus 로고
    • Aspirin for secondary prevention after acute myocardial infarction in the elderly: Prescribed use and outcomes
    • Krumholz HM, Radford MJ, Ellerbeck EF, et al. Aspirin for secondary prevention after acute myocardial infarction in the elderly: prescribed use and outcomes. Ann Intern Med. 1996 ; 124 (3). 292-298
    • (1996) Ann Intern Med , vol.124 , Issue.3 , pp. 292-298
    • Krumholz, H.M.1    Radford, M.J.2    Ellerbeck, E.F.3
  • 11
    • 0029866182 scopus 로고    scopus 로고
    • Patterns of aspirin use in middle-aged adults: The Atherosclerosis Risk in Communities (ARIC) Study
    • Shahar E, Folsom AR, Romm FJ, et al. Patterns of aspirin use in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J. 1996 ; 131 (5). 915-922
    • (1996) Am Heart J , vol.131 , Issue.5 , pp. 915-922
    • Shahar, E.1    Folsom, A.R.2    Romm, F.J.3
  • 12
    • 0034646206 scopus 로고    scopus 로고
    • Aspirin use is low among United States outpatients with coronary artery disease
    • Stafford RS. Aspirin use is low among United States outpatients with coronary artery disease. Circulation. 2000 ; 101 (10). 1097-1101
    • (2000) Circulation , vol.101 , Issue.10 , pp. 1097-1101
    • Stafford, R.S.1
  • 13
    • 72049091998 scopus 로고    scopus 로고
    • Use of antithrombotic agents among U.S. Stroke survivors, 2000-2006
    • Cheng EM, Cohen SN, Lee ML, Vassar SD, Chen AY. Use of antithrombotic agents among U.S. stroke survivors, 2000-2006. Am J Prev Med. 2010 ; 38 (1). 47-53
    • (2010) Am J Prev Med , vol.38 , Issue.1 , pp. 47-53
    • Cheng, E.M.1    Cohen, S.N.2    Lee, M.L.3    Vassar, S.D.4    Chen, A.Y.5
  • 14
    • 3042512305 scopus 로고    scopus 로고
    • Cardiovascular disease risk reduction in the Behavioral Risk Factor Surveillance System
    • Kim C, Beckles GL. Cardiovascular disease risk reduction in the Behavioral Risk Factor Surveillance System. Am J Prev Med. 2004 ; 27 (1). 1-7
    • (2004) Am J Prev Med , vol.27 , Issue.1 , pp. 1-7
    • Kim, C.1    Beckles, G.L.2
  • 15
    • 0035140649 scopus 로고    scopus 로고
    • Aspirin use among adults with diabetes: Estimates from the Third National Health and Nutrition Examination Survey
    • Rolka DB, Fagot-Campagna A, Narayan KM. Aspirin use among adults with diabetes: estimates from the Third National Health and Nutrition Examination Survey. Diabetes Care. 2001 ; 24 (2). 197-201
    • (2001) Diabetes Care , vol.24 , Issue.2 , pp. 197-201
    • Rolka, D.B.1    Fagot-Campagna, A.2    Narayan, K.M.3
  • 16
    • 29644436413 scopus 로고    scopus 로고
    • Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease
    • Stafford RS, Monti V, Ma J. Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease. PLoS Med. 2005 ; 2 (12). e353
    • (2005) PLoS Med , vol.2 , Issue.12 , pp. 353
    • Stafford, R.S.1    Monti, V.2    Ma, J.3
  • 18
    • 80053344963 scopus 로고    scopus 로고
    • The "million Hearts" initiative - Preventing heart attacks and strokes
    • Frieden TR, Berwick DM. The "Million Hearts" initiative - preventing heart attacks and strokes. N Engl J Med. 2011 ; 365 (13). e27
    • (2011) N Engl J Med , vol.365 , Issue.13 , pp. 27
    • Frieden, T.R.1    Berwick, D.M.2
  • 19
    • 64649091484 scopus 로고    scopus 로고
    • Aspirin noncompliance is the major cause of "aspirin resistance" in patients undergoing coronary stenting
    • Cuisset T, Frere C, Quilici J, et al. Aspirin noncompliance is the major cause of "aspirin resistance" in patients undergoing coronary stenting. Am Heart J. 2009 ; 157 (5). 889-893
    • (2009) Am Heart J , vol.157 , Issue.5 , pp. 889-893
    • Cuisset, T.1    Frere, C.2    Quilici, J.3
  • 20
    • 52049106554 scopus 로고    scopus 로고
    • Non-compliance is the predominant cause of aspirin resistance in chronic coronary arterial disease patients
    • Schwartz KA, Schwartz DE, Barber K, Reeves M, De Franco AC. Non-compliance is the predominant cause of aspirin resistance in chronic coronary arterial disease patients. J Transl Med. 2008 ; 6: 46
    • (2008) J Transl Med , vol.6 , pp. 46
    • Schwartz, K.A.1    Schwartz, D.E.2    Barber, K.3    Reeves, M.4    De Franco, A.C.5
  • 21
    • 10744228434 scopus 로고    scopus 로고
    • Lack of aspirin effect: Aspirin resistance or resistance to taking aspirin?
    • Cotter G, Shemesh E, Zehavi M, et al. Lack of aspirin effect: aspirin resistance or resistance to taking aspirin?. Am Heart J. 2004 ; 147 (2). 293-300
    • (2004) Am Heart J , vol.147 , Issue.2 , pp. 293-300
    • Cotter, G.1    Shemesh, E.2    Zehavi, M.3
  • 22
    • 0016805004 scopus 로고
    • The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein
    • Roth GJ, Majerus PW. The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein. J Clin Invest. 1975 ; 56 (3). 624-632
    • (1975) J Clin Invest , vol.56 , Issue.3 , pp. 624-632
    • Roth, G.J.1    Majerus, P.W.2
  • 23
    • 0017893621 scopus 로고
    • Inhibition of platelet prostaglandin synthetase by oral aspirin
    • Burch JW, Stanford N, Majerus PW. Inhibition of platelet prostaglandin synthetase by oral aspirin. J Clin Invest. 1978 ; 61 (2). 314-319
    • (1978) J Clin Invest , vol.61 , Issue.2 , pp. 314-319
    • Burch, J.W.1    Stanford, N.2    Majerus, P.W.3
  • 24
    • 0025909387 scopus 로고
    • Human platelet/erythroleukemia cell prostaglandin G/H synthase: CDNA cloning, expression, and gene chromosomal assignment
    • Funk CD, Funk LB, Kennedy ME, Pong AS, Fitzgerald GA. Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment. FASEB J. 1991 ; 5 (9). 2304-2312
    • (1991) FASEB J , vol.5 , Issue.9 , pp. 2304-2312
    • Funk, C.D.1    Funk, L.B.2    Kennedy, M.E.3    Pong, A.S.4    Fitzgerald, G.A.5
  • 25
    • 0022396676 scopus 로고
    • Clinical pharmacology of platelet cyclooxygenase inhibition
    • Patrono C, Ciabattoni G, Patrignani P, et al. Clinical pharmacology of platelet cyclooxygenase inhibition. Circulation. 1985 ; 72 (6). 1177-1184
    • (1985) Circulation , vol.72 , Issue.6 , pp. 1177-1184
    • Patrono, C.1    Ciabattoni, G.2    Patrignani, P.3
  • 26
    • 0029056992 scopus 로고
    • The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase
    • Loll PJ, Picot D, Garavito RM. The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase. Nat Struct Biol. 1995 ; 2 (8). 637-643
    • (1995) Nat Struct Biol , vol.2 , Issue.8 , pp. 637-643
    • Loll, P.J.1    Picot, D.2    Garavito, R.M.3
  • 27
    • 0019988413 scopus 로고
    • Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects
    • Patrignani P, Filabozzi P, Patrono C. Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. J Clin Invest. 1982 ; 69 (6). 1366-1372
    • (1982) J Clin Invest , vol.69 , Issue.6 , pp. 1366-1372
    • Patrignani, P.1    Filabozzi, P.2    Patrono, C.3
  • 28
    • 0030795143 scopus 로고    scopus 로고
    • Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina
    • Cipollone F, Patrignani P, Greco A, et al. Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina. Circulation. 1997 ; 96 (4). 1109-1116
    • (1997) Circulation , vol.96 , Issue.4 , pp. 1109-1116
    • Cipollone, F.1    Patrignani, P.2    Greco, A.3
  • 29
    • 0020692577 scopus 로고
    • Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man
    • FitzGerald GA, Oates JA, Hawiger J, et al. Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. J Clin Invest. 1983 ; 71 (3). 676-688
    • (1983) J Clin Invest , vol.71 , Issue.3 , pp. 676-688
    • Fitzgerald, G.A.1    Oates, J.A.2    Hawiger, J.3
  • 30
    • 0030022032 scopus 로고    scopus 로고
    • A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors
    • Brideau C, Kargman S, Liu S, et al. A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors. Inflamm Res. 1996 ; 45 (2). 68-74
    • (1996) Inflamm Res , vol.45 , Issue.2 , pp. 68-74
    • Brideau, C.1    Kargman, S.2    Liu, S.3
  • 31
    • 0035246513 scopus 로고    scopus 로고
    • Cyclooxygenase inhibitors - Current status and future prospects
    • Dannhardt G, Kiefer W. Cyclooxygenase inhibitors - current status and future prospects. Eur J Med Chem. 2001 ; 36 (2). 109-126
    • (2001) Eur J Med Chem , vol.36 , Issue.2 , pp. 109-126
    • Dannhardt, G.1    Kiefer, W.2
  • 32
    • 0027480087 scopus 로고
    • Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs
    • Meade EA, Smith WL, DeWitt DL. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem. 1993 ; 268 (9). 6610-6614
    • (1993) J Biol Chem , vol.268 , Issue.9 , pp. 6610-6614
    • Meade, E.A.1    Smith, W.L.2    Dewitt, D.L.3
  • 33
    • 0027146692 scopus 로고
    • Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase
    • Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, Vane JR. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci U S A. 1993 ; 90 (24). 11693-11697
    • (1993) Proc Natl Acad Sci U S A , vol.90 , Issue.24 , pp. 11693-11697
    • Mitchell, J.A.1    Akarasereenont, P.2    Thiemermann, C.3    Flower, R.J.4    Vane, J.R.5
  • 34
    • 0020558909 scopus 로고
    • Ibuprofen protects platelet cyclooxygenase from irreversible inhibition by aspirin
    • Rao GH, Johnson GG, Reddy KR, White JG. Ibuprofen protects platelet cyclooxygenase from irreversible inhibition by aspirin. Arteriosclerosis. 1983 ; 3 (4). 383-388
    • (1983) Arteriosclerosis , vol.3 , Issue.4 , pp. 383-388
    • Rao, G.H.1    Johnson, G.G.2    Reddy, K.R.3    White, J.G.4
  • 35
    • 0035924765 scopus 로고    scopus 로고
    • Cyclooxygenase inhibitors and the antiplatelet effects of aspirin
    • Catella-Lawson F, Reilly MP, Kapoor SC, et al. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med. 2001 ; 345 (25). 1809-1817
    • (2001) N Engl J Med , vol.345 , Issue.25 , pp. 1809-1817
    • Catella-Lawson, F.1    Reilly, M.P.2    Kapoor, S.C.3
  • 36
    • 0020360347 scopus 로고
    • Indomethacin prevents the long-lasting inhibitory effect of aspirin on human platelet cyclo-oxygenase activity
    • Livio M, Del Maschio A, Cerletti C, de Gaetano G. Indomethacin prevents the long-lasting inhibitory effect of aspirin on human platelet cyclo-oxygenase activity. Prostaglandins. 1982 ; 23 (6). 787-796
    • (1982) Prostaglandins , vol.23 , Issue.6 , pp. 787-796
    • Livio, M.1    Del Maschio, A.2    Cerletti, C.3    De Gaetano, G.4
  • 37
    • 17144407991 scopus 로고    scopus 로고
    • Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects
    • Capone ML, Sciulli MG, Tacconelli S, et al. Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects. J Am Coll Cardiol. 2005 ; 45 (8). 1295-1301
    • (2005) J Am Coll Cardiol , vol.45 , Issue.8 , pp. 1295-1301
    • Capone, M.L.1    Sciulli, M.G.2    Tacconelli, S.3
  • 38
    • 0030010696 scopus 로고    scopus 로고
    • Synthesis and use of iodinated nonsteroidal antiinflammatory drug analogs as crystallographic probes of the prostaglandin H2 synthase cyclooxygenase active site
    • Loll PJ, Picot D, Ekabo O, Garavito RM. Synthesis and use of iodinated nonsteroidal antiinflammatory drug analogs as crystallographic probes of the prostaglandin H2 synthase cyclooxygenase active site. Biochemistry. 1996 ; 35 (23). 7330-7340
    • (1996) Biochemistry , vol.35 , Issue.23 , pp. 7330-7340
    • Loll, P.J.1    Picot, D.2    Ekabo, O.3    Garavito, R.M.4
  • 39
    • 0021022903 scopus 로고
    • Arachidonate metabolism in vascular disorders
    • Majerus PW. Arachidonate metabolism in vascular disorders. J Clin Invest. 1983 ; 72 (5). 1521-1525
    • (1983) J Clin Invest , vol.72 , Issue.5 , pp. 1521-1525
    • Majerus, P.W.1
  • 40
    • 0016748441 scopus 로고
    • Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides
    • Hamberg M, Svensson J, Samuelsson B. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci U S A. 1975 ; 72 (8). 2994-2998
    • (1975) Proc Natl Acad Sci U S A , vol.72 , Issue.8 , pp. 2994-2998
    • Hamberg, M.1    Svensson, J.2    Samuelsson, B.3
  • 41
    • 0025282786 scopus 로고
    • Thromboxane biosynthesis and platelet function in type II diabetes mellitus
    • Davi G, Catalano I, Averna M, et al. Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N Engl J Med. 1990 ; 322 (25). 1769-1774
    • (1990) N Engl J Med , vol.322 , Issue.25 , pp. 1769-1774
    • Davi, G.1    Catalano, I.2    Averna, M.3
  • 42
    • 77957113521 scopus 로고    scopus 로고
    • Reduced platelet response to aspirin in patients with coronary artery disease and type 2 diabetes mellitus
    • Mortensen SB, Larsen SB, Grove EL, Kristensen SD, Hvas AM. Reduced platelet response to aspirin in patients with coronary artery disease and type 2 diabetes mellitus. Thromb Res. 2010 ; 126 (4). e318 - e322
    • (2010) Thromb Res , vol.126 , Issue.4
    • Mortensen, S.B.1    Larsen, S.B.2    Grove, E.L.3    Kristensen, S.D.4    Hvas, A.M.5
  • 43
    • 0029875851 scopus 로고    scopus 로고
    • Passive smoking and platelet thromboxane
    • Schmid P, Karanikas G, Kritz H, et al. Passive smoking and platelet thromboxane. Thromb Res. 1996 ; 81 (4). 451-460
    • (1996) Thromb Res , vol.81 , Issue.4 , pp. 451-460
    • Schmid, P.1    Karanikas, G.2    Kritz, H.3
  • 44
    • 0026487859 scopus 로고
    • Tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in women stratified by age
    • Rangemark C, Benthin G, Granstrom EF, Persson L, Winell S, Wennmalm A. Tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in women stratified by age. Circulation. 1992 ; 86 (5). 1495-1500
    • (1992) Circulation , vol.86 , Issue.5 , pp. 1495-1500
    • Rangemark, C.1    Benthin, G.2    Granstrom, E.F.3    Persson, L.4    Winell, S.5    Wennmalm, A.6
  • 45
    • 0025845334 scopus 로고
    • Relation between tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in young men
    • Wennmalm A, Benthin G, Granstrom EF, Persson L, Petersson AS, Winell S. Relation between tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in young men. Circulation. 1991 ; 83 (5). 1698-1704
    • (1991) Circulation , vol.83 , Issue.5 , pp. 1698-1704
    • Wennmalm, A.1    Benthin, G.2    Granstrom, E.F.3    Persson, L.4    Petersson, A.S.5    Winell, S.6
  • 46
    • 84898967872 scopus 로고    scopus 로고
    • [package insert]. Ann Arbor, MI: Cayman Chemical Company
    • 2 EIA Kit [package insert]. Ann Arbor, MI: Cayman Chemical Company; 2012.
    • (2012) 2 EIA Kit
  • 47
    • 0035144529 scopus 로고    scopus 로고
    • A comparison of every-third-day versus daily low-dose aspirin therapy on serum thromboxane concentrations in healthy men and women
    • Feldman M, Cryer B, Rushin K, Betancourt J. A comparison of every-third-day versus daily low-dose aspirin therapy on serum thromboxane concentrations in healthy men and women. Clin Appl Thromb Hemost. 2001 ; 7 (1). 53-57
    • (2001) Clin Appl Thromb Hemost , vol.7 , Issue.1 , pp. 53-57
    • Feldman, M.1    Cryer, B.2    Rushin, K.3    Betancourt, J.4
  • 48
    • 0035875796 scopus 로고    scopus 로고
    • Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: A placebo-controlled study using a highly sensitive C-reactive protein assay
    • Feldman M, Jialal I, Devaraj S, Cryer B. Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: a placebo-controlled study using a highly sensitive C-reactive protein assay. J Am Coll Cardiol. 2001 ; 37 (8). 2036-2041
    • (2001) J Am Coll Cardiol , vol.37 , Issue.8 , pp. 2036-2041
    • Feldman, M.1    Jialal, I.2    Devaraj, S.3    Cryer, B.4
  • 49
    • 0026670659 scopus 로고
    • Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin
    • Tohgi H, Konno S, Tamura K, Kimura B, Kawano K. Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin. Stroke. 1992 ; 23 (10). 1400-1403
    • (1992) Stroke , vol.23 , Issue.10 , pp. 1400-1403
    • Tohgi, H.1    Konno, S.2    Tamura, K.3    Kimura, B.4    Kawano, K.5
  • 50
    • 77749289650 scopus 로고    scopus 로고
    • Effect of two doses of aspirin on thromboxane biosynthesis and platelet function in patients undergoing coronary surgery
    • Brambilla M, Parolari A, Camera M, et al. Effect of two doses of aspirin on thromboxane biosynthesis and platelet function in patients undergoing coronary surgery. Thromb Haemost. 2010 ; 103 (3). 516-524
    • (2010) Thromb Haemost , vol.103 , Issue.3 , pp. 516-524
    • Brambilla, M.1    Parolari, A.2    Camera, M.3
  • 51
    • 0038370082 scopus 로고    scopus 로고
    • Aspirin dosage and thromboxane synthesis in patients with vascular disease
    • Hart RG, Leonard AD, Talbert RL, et al. Aspirin dosage and thromboxane synthesis in patients with vascular disease. Pharmacotherapy. 2003 ; 23 (5). 579-584
    • (2003) Pharmacotherapy , vol.23 , Issue.5 , pp. 579-584
    • Hart, R.G.1    Leonard, A.D.2    Talbert, R.L.3
  • 52
    • 83455196215 scopus 로고    scopus 로고
    • Impact of a fixed-dose combination of naproxen and esomeprazole magnesium on serum thromboxane B2 inhibition by low-dose aspirin over 5 days in healthy adults: A phase I, randomized, double-blind, placebo-controlled, noninferiority trial
    • Angiolillo DJ, Hwang C, Datto C, Desai B, Sostek M. Impact of a fixed-dose combination of naproxen and esomeprazole magnesium on serum thromboxane B2 inhibition by low-dose aspirin over 5 days in healthy adults: a phase I, randomized, double-blind, placebo-controlled, noninferiority trial. Clin Ther. 2011 ; 33 (12). 1883-1893
    • (2011) Clin Ther , vol.33 , Issue.12 , pp. 1883-1893
    • Angiolillo, D.J.1    Hwang, C.2    Datto, C.3    Desai, B.4    Sostek, M.5
  • 53
    • 70350346840 scopus 로고    scopus 로고
    • The interaction of ibuprofen and diclofenac with aspirin in healthy volunteers
    • Schuijt MP, Huntjens-Fleuren HW, de Metz M, Vollaard EJ. The interaction of ibuprofen and diclofenac with aspirin in healthy volunteers. Br J Pharmacol. 2009 ; 157 (6). 931-934
    • (2009) Br J Pharmacol , vol.157 , Issue.6 , pp. 931-934
    • Schuijt, M.P.1    Huntjens-Fleuren, H.W.2    De Metz, M.3    Vollaard, E.J.4
  • 55
    • 77952466833 scopus 로고    scopus 로고
    • Effect of maximum OTC doses of naproxen sodium or acetaminophen on low-dose aspirin inhibition of serum thromboxane B2
    • Oldenhof J, Hochberg M, Schiff M, Brune K. Effect of maximum OTC doses of naproxen sodium or acetaminophen on low-dose aspirin inhibition of serum thromboxane B2. Curr Med Res Opin. 2010 ; 26 (6). 1497-1504
    • (2010) Curr Med Res Opin , vol.26 , Issue.6 , pp. 1497-1504
    • Oldenhof, J.1    Hochberg, M.2    Schiff, M.3    Brune, K.4
  • 56
    • 16244374947 scopus 로고    scopus 로고
    • Double-blind, randomized, parallel, placebo-controlled study of ibuprofen effects on thromboxane B2 concentrations in aspirin-treated healthy adult volunteers
    • Cryer B, Berlin RG, Cooper SA, Hsu C, Wason S. Double-blind, randomized, parallel, placebo-controlled study of ibuprofen effects on thromboxane B2 concentrations in aspirin-treated healthy adult volunteers. Clin Ther. 2005 ; 27 (2). 185-191
    • (2005) Clin Ther , vol.27 , Issue.2 , pp. 185-191
    • Cryer, B.1    Berlin, R.G.2    Cooper, S.A.3    Hsu, C.4    Wason, S.5
  • 57
    • 64649098177 scopus 로고    scopus 로고
    • Optical platelet aggregation versus thromboxane metabolites in healthy individuals and patients with stable coronary artery disease after low-dose aspirin administration
    • Hedegaard SS, Hvas AM, Grove EL, et al. Optical platelet aggregation versus thromboxane metabolites in healthy individuals and patients with stable coronary artery disease after low-dose aspirin administration. Thromb Res. 2009 ; 124 (1). 96-100
    • (2009) Thromb Res , vol.124 , Issue.1 , pp. 96-100
    • Hedegaard, S.S.1    Hvas, A.M.2    Grove, E.L.3
  • 58
    • 33747088257 scopus 로고    scopus 로고
    • Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: A 700-patient study of aspirin resistance
    • Frelinger AL, Furman MI, Linden MD, et al. Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance. Circulation. 2006 ; 113 (25). 2888-2896
    • (2006) Circulation , vol.113 , Issue.25 , pp. 2888-2896
    • Frelinger, A.L.1    Furman, M.I.2    Linden, M.D.3
  • 59
    • 33747168513 scopus 로고    scopus 로고
    • Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers
    • Cox D, Maree AO, Dooley M, Conroy R, Byrne MF, Fitzgerald DJ. Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers. Stroke. 2006 ; 37 (8). 2153-2158
    • (2006) Stroke , vol.37 , Issue.8 , pp. 2153-2158
    • Cox, D.1    Maree, A.O.2    Dooley, M.3    Conroy, R.4    Byrne, M.F.5    Fitzgerald, D.J.6
  • 60
    • 77953160638 scopus 로고    scopus 로고
    • A comparison of platelet function tests and thromboxane metabolites to evaluate aspirin response in healthy individuals and patients with coronary artery disease
    • Grove EL, Hvas AM, Johnsen HL, et al. A comparison of platelet function tests and thromboxane metabolites to evaluate aspirin response in healthy individuals and patients with coronary artery disease. Thromb Haemost. 2010 ; 103 (6). 1245-1253
    • (2010) Thromb Haemost , vol.103 , Issue.6 , pp. 1245-1253
    • Grove, E.L.1    Hvas, A.M.2    Johnsen, H.L.3
  • 61
    • 38949119325 scopus 로고    scopus 로고
    • Aspirin "resistance" and risk of cardiovascular morbidity: Systematic review and meta-analysis
    • Krasopoulos G, Brister SJ, Beattie WS, Buchanan MR. Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis. BMJ. 2008 ; 336 (7637). 195-198
    • (2008) BMJ , vol.336 , Issue.7637 , pp. 195-198
    • Krasopoulos, G.1    Brister, S.J.2    Beattie, W.S.3    Buchanan, M.R.4
  • 62
    • 47749143702 scopus 로고    scopus 로고
    • Residual platelet reactivity on aspirin therapy and recurrent cardiovascular events - A meta-analysis
    • Sofi F, Marcucci R, Gori AM, Abbate R, Gensini GF. Residual platelet reactivity on aspirin therapy and recurrent cardiovascular events - a meta-analysis. Int J Cardiol. 2008 ; 128 (2). 166-171
    • (2008) Int J Cardiol , vol.128 , Issue.2 , pp. 166-171
    • Sofi, F.1    Marcucci, R.2    Gori, A.M.3    Abbate, R.4    Gensini, G.F.5
  • 63
    • 34547760330 scopus 로고    scopus 로고
    • A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease
    • Lordkipanidzé M, Pharand C, Schampaert E, Turgeon J, Palisaitis DA, Diodati JG. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease. Eur Heart J. 2007 ; 28 (14). 1702-1708
    • (2007) Eur Heart J , vol.28 , Issue.14 , pp. 1702-1708
    • Lordkipanidzé, M.1    Pharand, C.2    Schampaert, E.3    Turgeon, J.4    Palisaitis, D.A.5    Diodati, J.G.6
  • 64
    • 34347340649 scopus 로고    scopus 로고
    • Evaluation of dose-related effects of aspirin on platelet function: Results from the Aspirin-Induced Platelet Effect (ASPECT) study
    • Gurbel PA, Bliden KP, DiChiara J, et al. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study. Circulation. 2007 ; 115 (25). 3156-3164
    • (2007) Circulation , vol.115 , Issue.25 , pp. 3156-3164
    • Gurbel, P.A.1    Bliden, K.P.2    Dichiara, J.3
  • 65
    • 70350441936 scopus 로고    scopus 로고
    • Response to aspirin in healthy individuals. Cross-comparison of light transmission aggregometry, VerifyNow system, platelet count drop, thromboelastography (TEG) and urinary 11-dehydrothromboxane B(2)
    • Blais N, Pharand C, Lordkipanidze M, Sia YK, Merhi Y, Diodati JG. Response to aspirin in healthy individuals. Cross-comparison of light transmission aggregometry, VerifyNow system, platelet count drop, thromboelastography (TEG) and urinary 11-dehydrothromboxane B(2). Thromb Haemost. 2009 ; 102 (2). 404-411
    • (2009) Thromb Haemost , vol.102 , Issue.2 , pp. 404-411
    • Blais, N.1    Pharand, C.2    Lordkipanidze, M.3    Sia, Y.K.4    Merhi, Y.5    Diodati, J.G.6
  • 66
    • 60049093774 scopus 로고    scopus 로고
    • Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: Implications for aspirin "resistance"
    • Santilli F, Rocca B, De Cristofaro R, et al. Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". J Am Coll Cardiol. 2009 ; 53 (8). 667-677
    • (2009) J Am Coll Cardiol , vol.53 , Issue.8 , pp. 667-677
    • Santilli, F.1    Rocca, B.2    De Cristofaro, R.3
  • 67
    • 60749114799 scopus 로고    scopus 로고
    • Interindividual variability in the response to oral antiplatelet drugs: A position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology
    • Kuliczkowski W, Witkowski A, Polonski L, et al. Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology. Eur Heart J. 2009 ; 30 (4). 426-435
    • (2009) Eur Heart J , vol.30 , Issue.4 , pp. 426-435
    • Kuliczkowski, W.1    Witkowski, A.2    Polonski, L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.